Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Maricann Group Inc. (MARI-CN) reported second-quarter revenue of $1.2-million as compared to $661,602 during the same period in 2017. “The increase in revenue during the three months ended June 30, 2018 compared to June 30, 2017 is primarily related to two large bulk supply orders completed during Q2 2018,” the company stated.

Its net loss was $9.9-million or 7 cents per share versus a profit of $14-million or 20 cents a year earlier. The company said the larger net loss was due to an increase in "operational and other working capital uses consistent with a company on a steep growth curve. "

Story continues below advertisement

**

Tahoe Resources Inc. (THO-T; TAHO-N) says 12 unarmed security contract workers with its subsidiary Minera San Rafael S.A., behind its Escobal silver mine in Guatemala, were attacked and kidnapped on Friday and were released after several hours of being abducted, injured and held at gunpoint.

The abductors identified themselves as the “Peaceful Resistance Group of Mataquescuintla," the company stated.

Tahoe CEO Jim Voorhees said the company is treating the developments “with the utmost seriousness and are taking appropriate measures to ensure the safety and security of all of our employees and contractors, their families, and local community members.”

**

GTEC Holdings Ltd. (GTEC-X) has signed a cannabis supply agreement with Namaste Technologies Inc. (N-X) subsidiary Cannmart Inc. that sees Cannmart purchase cannabis flower and oil from GTEC for resale on Cannmart’s online platform.

"The supply agreement is consistent with GTEC's strategy of diversifying its sales mix by pursuing supply agreements with a select group of partners," the company stated.

Story continues below advertisement

**

BSM Technologies Inc. (GPS-T) has appointed Louis De Jong as its president and CE effective immediately.

The company said Aly Rahemtulla resigned effective today as president, CEO and from the board.

Mr. De Jong first joined BSM as its chief financial officer in 2014. Stephen De Bolster has been named interim CFO. Mr. De Bolster most recently served as its vice-president, finance.

**

CannaRoyalty Corp. (CRZ-CN) says it has a binding letter of intent that sees Tidal Royalty Corp., a provider of royalty financing to licensed U.S. cannabis operators, buy CannaRoyalty’s equity stake and royalty entitlement in Alternative Medical Enterprises LLC for $8-million in cash and stock.

Story continues below advertisement

AltMed is a licensed cannabis business operating in Florida that manufactures and distributes a line of cannabis-infused products marketed under the MÜV™ brand. CannaRoyalty said it will maintain the right to license MÜV products in California, Nevada, Canada and other select markets.

CannaRoyalty currently holds a 6-per-cent ownership position in AltMed and has a 3.5-per-cent royalty on global net sales on some MüV products.

**

WeedMD Inc. (WMD-X) says it has entered into a purchase agreement with the Nova Scotia Liquor Corp. to supply its branded cannabis products for the adult-use cannabis market in Nova Scotia.

CEO Keith Merker said the company is amongst a "select group of licensed producers who have been given the opportunity to supply Nova Scotia."

WeedMD has also entered into cannabis supply arrangements with the Alberta Gaming, Liquor & Cannabis Commission and the British Columbia Liquor Distribution Branch and has an agreement to become a medical cannabis supplier to Shoppers Drug Mart, subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed distributor.

**

Emerald Health Therapeutics, Inc. (EMH-X) has signed a term sheet to form a strategic alliance with Factors R&D Technology, Inc., a division of Factors Group of Nutritional Companies Inc.

"In this exclusive arrangement, FTI will provide to Emerald pharmaceutical-grade, industrial-scale manufacturing capacity as well as expertise in GMP-level extraction, softgel production, and packaging focused on the rapidly emerging market opportunities for medicinal cannabis in Canada and internationally," Emerald stated. "This collaboration leverages the Factors Group’s decades of experience in product development, formulation and innovation."

**

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter